The most common antigens are gp and a previously unknown protein dubbed MART. 흑색종 대부분은 이러한 항원 중 하나 이상을 발현하며, 대부분 MART를 발현합니다. Phase I immunotherapy trials using TILs that had been altered to recognize MART and gp in metastatic melanoma patients began in early.